Overcoming Clinical Trial Challenges in Emerging Markets

In this short video interview, which took place at the Clinical Trials Supply Europe event earlier this year, Michael Pompey from Sandoz Biopharmaceuticals explains the biggest challenges he faces is working with clinical groups to choose the right countries to outsource clinical trials to. This followed by transportation into sites from local depots in emerging markets. There are challenges around emerging markets and standardisation needs to be implemented to help the trials run more smoothly.